- ASLAN Pharmaceuticals Limited (NASDAQ:ASLN) +71% as ASLAN004 shows positive effect in atopic dermatitis.
- Apollo Endosurgery (NASDAQ:APEN) +47% after receiving a Breakthrough Device Designation from the USFDA for the Orbera® Intragastric Balloon.
- electroCore (NASDAQ:ECOR) +39% on exclusive distribution deal with Medistar.
- Satsuma Pharmaceuticals (NASDAQ:STSA) +26% after updating STS101 development plan.
- SOS Limited (NYSE:SOS) +23% after responding to "Short and Distort" allegations.
- BriaCell Therapeutics (BCTX) +20%.
- Socket Mobile (NASDAQ:SCKT) +18% on inking licensing agreement with SpringCard SAS.
- OpGen, Inc. (NASDAQ:OPGN) +18% on Chinese approval of Curetis Unyvero System.
- Vector Acquisition Corporation (VACQU) +18% as Rocket Lab to go public via merger with the company.
- Canaan Inc. (NASDAQ:CAN) +18%.
- Phio Pharmaceuticals Corp. (NASDAQ:PHIO) +17% on collaboration with AgonOx.
- Lion Group Holding Ltd. (NASDAQ:LGHL) +17% after announcing sponsorship of a SPAC Company.
- Novan, Inc. (NASDAQ:NOVN) +17% on FY'20 results.
- SRAX, Inc. (NASDAQ:SRAX) +16%.
- COMSovereign Holding Corp. (NASDAQ:COMS) +15% on acquiring Sky Sapience.
- Marathon Patent Group (NASDAQ:MARA) +15%.
- WiMi Hologram Cloud (NASDAQ:WIMI) +14% after strategic cooperation with the Dream Classroom program of China Education Television.
- Taoping (NASDAQ:TAOP) +13%.
- Salarius Pharmaceuticals (NASDAQ:SLRX) +13%.
- KemPharm (NASDAQ:KMPH) +13%.
- The9 Limited (NASDAQ:NCTY) +13%.
- Houston American Energy Corp. (NYSE:HUSA) +13%.
- Brickell Biotech (NASDAQ:BBI) +13%.
- Tuniu Corporation (NASDAQ:TOUR) +12%.
- Stratasys Ltd. (NASDAQ:SSYS) +11%. on Q4 results
SSYS, MARA, SOS and CAN among premarket gainers
ASLAN Pharmaceuticals Limited (ASLN) Stock, BSX Stock, ECOR Stock, STSA Stock, SOS Stock, SCKT Stock, OPGN Stock, RKLB Stock, CAN Stock, PHIO Stock, LGHL Stock, NOVNQ Stock, FRHC Stock, COMS Stock, MARA Stock, WIMI Stock, TAOP Stock, SLRX Stock, ZVRA Stock, NCTY Stock, HUSA Stock, FRTX Stock, TOUR Stock, SSYS StockSA News Team